InvestorsHub Logo

flipper44

02/02/24 11:34 AM

#669564 RE: abeta #669562

That’s the abstract of the overall paper I was talking about in the post you responded to. It was cited in the thread.

H2R

02/02/24 4:20 PM

#669659 RE: abeta #669562

Thanks abeta. The p-values are telling!



Results Median survival was 21.7 months in the immunotherapy group (95% CI 4–37 months) and 15.8 months (95% CI 3–22 months) in the non-immunotherapy group (p = 0.002).

The median relapse-free period in the group with immunotherapy was 13.8 months (95% CI 1–20 months), and in the group without immunotherapy 7.9 months (95% CI 1–12 months) (p = 0.003).



Confirming if that was needed at this point the efficacy of dendritic cells !

Best of luck to Patients, NWBO, and Longs!
Bullish
Bullish